Wenyi Hou

Harbin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Transcriptome-based immune subtypes reveal the heterogeneity of tumor microenvironment in pediatric B-cell acute lymphocytic leukemia.

Transcriptome-based immune subtypes reveal the heterogeneity of tumor microenvironment in pediatric B-cell acute lymphocytic leukemia.

Journal: Frontiers in oncology

Published: June 08, 2025

Sustained release of cathepsin D/cathepsin K from injectable hydrogel microspheres in anti-photoaging.

Sustained release of cathepsin D/cathepsin K from injectable hydrogel microspheres in anti-photoaging.

Journal: Materials today. Bio

Published: May 28, 2025

Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis.

Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis.

Journal: Human vaccines & immunotherapeutics

Published: December 06, 2024

Study on clinical features of early death in older patients with acute promyelocytic leukemia.

Study on clinical features of early death in older patients with acute promyelocytic leukemia.

Journal: Annals of hematology

Published: June 13, 2024

Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide.

Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide.

Journal: Annals of hematology

Published: August 29, 2021

Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.

Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.

Journal: Annals of hematology

Published: November 21, 2020

Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.

Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.

Journal: Journal of cancer research and clinical oncology

Published: October 03, 2019

Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.

Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.

Journal: Blood cells, molecules & diseases

Published: July 11, 2019

Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death.

Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death.

Journal: Cancer management and research

Published: October 02, 2018

Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.

Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 05, 2018

Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.

Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.

Journal: Annals of hematology

Published: June 23, 2017

Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide.

Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide.

Journal: Annals of hematology

Published: June 20, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026